
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| Optic-unspecified(L) | 907 | 67.4% | -2.17 | 201 | 39.1% |
| AME(L) | 301 | 22.4% | -0.67 | 189 | 36.8% |
| CentralBrain-unspecified | 138 | 10.3% | -0.15 | 124 | 24.1% |
| upstream partner | # | NT | conns aMe6b | % In | CV |
|---|---|---|---|---|---|
| HBeyelet (L) | 4 | HA | 350 | 27.1% | 0.2 |
| aMe6c (L) | 2 | Glu | 337 | 26.1% | 0.2 |
| aMe1 (L) | 2 | GABA | 170 | 13.1% | 0.2 |
| MeVPMe12 (R) | 2 | ACh | 90 | 7.0% | 0.2 |
| MeVCMe1 (R) | 2 | ACh | 74 | 5.7% | 0.3 |
| MeVCMe1 (L) | 2 | ACh | 58 | 4.5% | 0.5 |
| aMe5 (L) | 15 | ACh | 58 | 4.5% | 0.9 |
| OA-AL2i3 (L) | 2 | OA | 54 | 4.2% | 0.2 |
| aMe23 (L) | 1 | Glu | 25 | 1.9% | 0.0 |
| aMe4 (L) | 7 | ACh | 15 | 1.2% | 0.5 |
| aMe22 (L) | 1 | Glu | 14 | 1.1% | 0.0 |
| aMe30 (L) | 2 | Glu | 10 | 0.8% | 0.6 |
| MeVPaMe1 (R) | 1 | ACh | 5 | 0.4% | 0.0 |
| aMe_TBD1 (L) | 1 | GABA | 5 | 0.4% | 0.0 |
| aMe12 (L) | 3 | ACh | 5 | 0.4% | 0.6 |
| aMe2 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| Cm21 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| l-LNv (R) | 1 | unc | 2 | 0.2% | 0.0 |
| aMe10 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| LoVC23 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm20 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeLo1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP249 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT58 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPLo1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm31a (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns aMe6b | % Out | CV |
|---|---|---|---|---|---|
| aMe4 (L) | 10 | ACh | 333 | 23.0% | 0.5 |
| aMe1 (L) | 2 | GABA | 181 | 12.5% | 0.1 |
| aMe10 (L) | 1 | ACh | 101 | 7.0% | 0.0 |
| aMe17b (L) | 3 | GABA | 96 | 6.6% | 0.1 |
| aMe5 (L) | 14 | ACh | 93 | 6.4% | 1.5 |
| MeVPMe12 (R) | 2 | ACh | 70 | 4.8% | 0.1 |
| aMe15 (L) | 1 | ACh | 63 | 4.4% | 0.0 |
| aMe6c (L) | 2 | Glu | 40 | 2.8% | 0.3 |
| Lat2 (L) | 2 | unc | 40 | 2.8% | 0.1 |
| MeVPMe12 (L) | 2 | ACh | 39 | 2.7% | 0.2 |
| aMe30 (L) | 2 | Glu | 36 | 2.5% | 0.1 |
| MeVPaMe2 (L) | 1 | Glu | 34 | 2.4% | 0.0 |
| MeVP29 (L) | 1 | ACh | 34 | 2.4% | 0.0 |
| OA-AL2i3 (L) | 2 | OA | 31 | 2.1% | 0.4 |
| aMe3 (L) | 1 | Glu | 27 | 1.9% | 0.0 |
| l-LNv (L) | 4 | unc | 27 | 1.9% | 0.6 |
| aMe_TBD1 (L) | 1 | GABA | 26 | 1.8% | 0.0 |
| s-LNv (L) | 4 | ACh | 20 | 1.4% | 0.6 |
| aMe_unclear (L) | 1 | Glu | 17 | 1.2% | 0.0 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 15 | 1.0% | 0.6 |
| SLP250 (L) | 1 | Glu | 12 | 0.8% | 0.0 |
| aMe23 (L) | 1 | Glu | 10 | 0.7% | 0.0 |
| aMe13 (L) | 1 | ACh | 8 | 0.6% | 0.0 |
| Lat1 (L) | 2 | unc | 8 | 0.6% | 0.2 |
| aMe2 (L) | 3 | Glu | 7 | 0.5% | 0.5 |
| SLP249 (L) | 1 | Glu | 6 | 0.4% | 0.0 |
| Cm35 (L) | 1 | GABA | 6 | 0.4% | 0.0 |
| aMe12 (L) | 3 | ACh | 6 | 0.4% | 0.4 |
| HBeyelet (L) | 4 | HA | 6 | 0.4% | 0.3 |
| aMe8 (L) | 1 | unc | 5 | 0.3% | 0.0 |
| aMe24 (L) | 1 | Glu | 4 | 0.3% | 0.0 |
| Cm1 (L) | 2 | ACh | 4 | 0.3% | 0.5 |
| aMe6a (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| MeLo7 (L) | 2 | ACh | 3 | 0.2% | 0.3 |
| CL125 (L) | 2 | Glu | 3 | 0.2% | 0.3 |
| Lat3 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| aMe26 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| LoVP53 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe17c (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVC20 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MeVP3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Dm2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| C2 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeLo2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP39 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Lat5 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVP54 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVCMe1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP28 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |